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Purpose: Stent-assisted coiling allows embolization and parent vessel reconstruction of wide-necked
intracranial aneurysms. The Neuroform EZ (Boston Scientific, Fremont, CA, U.S.A.) stent delivery sys-
tem offers deployment of a Neuroform stent with fewer steps and improved operator control.
Initial experience, technical considerations, and treatment outcomes using the Neuroform EZ stent
delivery system in combination with coil embolization are reported.
Materials and Methods: Seventeen consecutive patients harboring 21 wide-necked saccular cerebral
aneurysms were treated with stent reconstruction. Twenty aneurysms were unruptured; one was
treated within 24 hours of diagnosis of rupture. Twenty aneurysms were located in the anterior cir-
culation; one was in the posterior circulation. Immediate and six-month post-treatment angiogra-
phy and clinical assessment were performed. 
Results: In all cases, the stents were delivered and positioned without difficulty in deployment.
Technical complications occurred in 4 patients, but none were directly related to the stent delivery
system.  On immediate post-treatment angiography, 5 of 21 aneurysms showed complete occlu-
sion, 5 of 21 showed residual neck, and 11 of 21 showed residual contrast filling of the aneurysm
sac. At six month follow-up, all 17 patients were clinically stable.  Angiography of 18 of the
aneurysms showed total occlusion in 12, residual neck in 3, and residual aneurysm filling in 3.
Retreatment was performed in the three with residual aneurysm.
Conclusion: The Neuroform EZ stent system offers improved anchoring and support in stent delivery,
which is particularly useful when multiple stents are overlapped to further protect the parent vessel
and increase flow diversion away from the aneurysm sac.  The only significant problem encoun-
tered was coil prolapse, which could be treated with a second stent when necessary. The ease of
deployment improves upon the already clinically successful Neuroform design.
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http://dx.doi.org/10.5469/neuroint.2012.7.1.34Stent-assisted coiling for treatment of wide-necked
intracranial aneurysms has grown in popularity. Self-
expanding stents provide mechanical, hemodynamic,
and biological benefits by preventing coil protrusion
into the parent artery, reducing intra-aneurysmal flow,
and promoting vessel wall healing [1, 2]. The introduc-
tion of the first flexible intracranial Neuroform stent
(Boston Scientific, Fremont, CA, U.S.A.) and the
subsequent preliminary results have shown this device
to be an effective tool in treating pathological entities
that were previously not considered amenable to
endovascular therapy [3-9]. The Neuroform 3 Stent
Delivery System (previous version) is a preloaded stent
within a microcatheter that must be advanced en bloc
or  transferred  to  a  pre-positioned  alternate
microcatheter. En bloc advancement can be difficult in
tortuous anatomy, and stent transfer is time consuming,
wasteful, and complicated for a single operator. In this
article, we report our initial clinical experience, techni-
cal considerations, and treatment outcomes in 17
consecutive patients harboring a total of 21 wide-
necked aneurysms using the Neuroform EZ Stent
Delivery System, which incorporates a simplified,
single-operator delivery system intended to facilitate
stent preparation, delivery, and positioning. 
PATIENTS AND METHODS
Demographic data and inclusion criteria
Seventeen consecutive adult patients with 21 wide-
necked intracranial saccular aneurysms were included
in the study. Prior to treatment, the neurovascular team
considered the options of observation, open surgical
and endovascular repair in each case. Angiographic
studies obtained in all aneurysms were reviewed by the
attending endovascular neurosurgeon (D.K.L). All
saccular bifurcation aneurysms included in the study
had a wide neck, defined as a dome-to-neck ratio of
less than 2 or a neck that was 4 mm or wider as
measured on angiography [10, 11]. A signed informed
consent was obtained for each patient. Demographic
data obtained and recorded for each patient included
clinical history, aneurysm location and dimensions,
technical difficulties, and complications. Immediate
post-procedure angiography was performed to
determine degree of aneurysm occlusion and parent
vessel patency. A frequently updated database with the
aforementioned data was retrospectively reviewed.
This study was conducted in accordance to and with
approval by the Rush University Medical Center
Institutional Review Board.
Patient population
Between June, 2010 and September, 2010, we
deployed 30 Neuroform EZ stents in 17 patients (12
women) for treatment of 21 wide-necked cerebral
aneurysms. The mean age at the time of treatment was
56.3 years (range 37-79 years). Stents were deployed
in an overlapping manner in 7 patients, and a y-stent
configuration was used to reconstruct the parent vessels
of 2 aneurysms [12, 13]. There were 3 aneurysms
located at the cavernous carotid segment, 3 at the origin
of the ophthalmic artery, 4 at the superior hypophyseal
artery, 4 at the posterior communicating artery, 1 along
the posterior carotid wall, 1 on the A1 segment of
anterior cerebral artery, 2 at the anterior communicat-
ing artery, 2 at the middle cerebral artery bifurcation,
and 1 at the basilar bifurcation. The average maximum
diameter of the 21 aneurysms was 8.3 mm (range 2.5-
24.0 mm) with average neck 5.7 mm (range 2.0-17.9
mm). Three aneurysms initially treated via coiling only
were found to have recurrent filling on 6-month follow-
up; these were treated via stent-assisted coiling with the
Neuroform EZ stent and included in the study. In
unruptured and previously treated aneurysms, the
Neuroform EZ stent was placed across the neck of the
lesion prior to coil embolization. In the case of the one
acutely ruptured aneurysm, a Neuroform EZ stent was
deployed after coil embolization as post-coiling
angiography demonstrated parent artery compromise. 
Stent delivery method
Patients treated electively receive anti-platelet
pharmacotherapy (325 mg aspirin and 75 mg clopido-
grel daily) starting 5 days before the procedure. The
one patient who presented with subarachnoid
hemorrhage was loaded with anti-platelet medication
following the procedure. Intra-operative heparinization
to an activated clotting time of 250 seconds is
maintained throughout the procedure. Dual anti-platelet
therapy continues for three months after the procedure
and for six months when more than one stent is placed. 
After diagnostic angiography is performed, working
views are obtained for stent delivery. The appropriate
Neuroform EZ stent length is selected (lengths
available were 10, 15, 20 and 30 mm) to allow the ends
of the device to extend at least 5 mm beyond the neck
of the aneurysm on each side. All stents deployed were
4.5 mm in width to maximize vessel apposition and
increase metal to artery ratio.
A guide catheter is positioned in the cervical segment
of the target vessel. A microcatheter (Renegade Hi-
flow (Stryker) or Marksman (Covidien)) is navigated
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Neuroform EZ stent loading sheath is introduced into a
rotating hemostatic valve connected to the micro-
catheter and continuous heparinized saline flush. Back
flow of saline from the valve preps the system through
the loading sheath. The loading sheath is inserted to the
hub of the microcatheter and the rotating hemostatic
valve is tightened around the sheath. The stent is
introduced into the microcatheter under direct visual-
ization through the transparent tip of the loading
sheath. The stent and delivery system are then
advanced beyond the aneurysm neck within the
microcatheter; the microcatheter is withdrawn while
keeping forward pressure on the stent delivery system,
unsheathing the stent across the neck of the aneurysm.
The catheter can be manipulated forward and backward
to control speed of deployment and expansion of each
open cell unit.
Visualization of the four platinum marker bands at
each end of the stent confirms proximal and distal
placement within the parent vessel. After stent deploy-
ment, a Synchro 14 (Stryker) microguidewire and SL
10 microcatheter are advanced through the interstices
of the stent into the aneurysm to allow coil emboliza-
tion.
Anatomic and clinical outcome assessment
Patients were evaluated by angiography at the end of
the procedure to document aneurysm obliteration. A
qualitative assessment of aneurysm occlusion was
performed using a 3-point Raymond scale [14]: 1)
complete aneurysm occlusion without contrast filling;
2) residual neck; and 3) residual aneurysm sac. In all
cases, aneurysm occlusion was interpreted on the basis
of the images obtained immediately after placement of
the last coil. The senior author evaluated the clinical
outcome at discharge and follow-up with modified
Rankin score (mRS) [15]. Six-month follow-up angiog-
raphy was performed on 18 of the 21 treated
aneurysms. Two patients with a total of 3 aneurysms
are clinically stable but are still awaiting angiographic
follow-up.
RESULTS
Precise delivery of the stent was successfully
performed in all cases. Navigation of the stent delivery
system was accomplished without difficulty through
tortuous internal carotid and vertebral arteries. There
were no technical complications with stent delivery. In
cases where multiple stents were positioned in an
overlapping fashion, the microcatheter could be re-
advanced over the stent-deployment wire through the
deployed stent. After deployment, no stents required
retrieval or repositioning. No artery branch occlusion
due to intra-stent thrombus was demonstrated
angiographically, and no thromboembolic complica-
tions, arterial dissections, or arterial ruptures occurred
during stent placement. 
All of the aneurysms both ruptured and unruptured
underwent coil embolization in the same setting as
stent placement. Navigation of the microcatheter
through the interstices of the stent was easily
accomplished in all cases. Microcatheter manipulation
during coil embolization of the aneurysm did not cause
stents to move from the site of original placement.
On immediate post-embolization angiography, 5
aneurysms showed complete occlusion, 5 showed
contrast filling the neck of the aneurysm, and 12 showed
contrast filling the sac of the aneurysm (Table 1).
Technical Difficulties
Technical complications occurred in 4 patients,
including prolapsed coils, vasospasm, and parent vessel
compromise, all of which had no clinical significance. 
In case 5, a Neuroform EZ stent was placed across a
wide-necked superior hypophyseal artery aneurysm
followed by coiling. Unfortunately, the first coil
stretched and prolapsed into the parent vessel. An
Enterprise stent (Codman, Miami Lakes, FL, U.S.A.)
was deployed, overlapping the Neuroform EZ stent to
keep the prolapsed coil segment out of the vessel
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Table 1. Angiographic Results 
Initial Raymond Class 6-month follow-up Raymond Class*
Retreat
I II III I II III
Total 5 5 11 12 3 3 3
<10 mm 3 4 8 11 2 0 0
>10 mm 2 1 3 1 1 3 3
* Follow-up angiography unavailable for three patients who are known to be clinically stable.lumen. In case 8, after deployment of a Neuroform EZ
stent across the neck of a carotid ophthalmic artery
aneurysm and carotid cavernous aneurysm, coil
packing of the two separate aneurysms through the
stent initially resulted in partial prolapse of coil mass
into the parent vessel. A second Neuroform EZ stent
was placed successfully. Post-procedure angiography
demonstrated no parent vessel compromise in these
two cases, nor were there any clinical sequelae.
In case 13, after coiling a basilar tip aneurysm, post-
procedure angiography demonstrated prolapsed coils,
occluding the small left posterior cerebral artery. A
Neuroform EZ stent was placed from the right
posterior cerebral artery to basilar artery. Prior to
closure, a left common carotid artery angiogram
demonstrated a fetal origin of the left posterior cerebral
artery. The patient remained neurologically intact.
In case 14, while treating a wide-necked anterior
communicating artery aneurysm, there was iatrogenic
vasospasm resulting in mild changes in somatosensory
evoked potentials. Potentials returned to baseline after
use of intra-arterial nicardipine and blood pressure
augmentation. The patient had no new neurologic
deficits after the procedure.
Clinical Outcome
Selective embolization was successfully performed
and resulted in an excellent clinical outcome in all
patients. One patient had a groin hematoma without
evidence of pseudoaneurysm or arteriovenous fistula
on ultrasound and without clinical sequelae. One
patient had elevated troponins post-procedure related to
demand ischemia without clinical consequence. There
were no treatment-related deaths or clinically evident
neurological complications. The one patient who
presented  in  the  acute  stage  of  subarachnoid
hemorrhage (ruptured basilar tip aneurysm) did well
post-operatively and was discharged home on post-
operative day 11. All seventeen patients were
discharged home with a good clinical status (mRS 0, n
= 11; mRS 1, n = 6). All patients were clinically
evaluated approximately six months after aneurysm
treatment, and none had evidence of treatment-related
complications. 
Follow-up angiography (Table 1) showed total
occlusion in 12, residual neck in 3, and residual
aneurysm filling in 3. Retreatment was performed for
the three aneurysms with residual filling. Two of these
had further coiling for coil compaction without compli-
cation; follow-up angiography of these retreatments is
pending. The third patient also had further coiling for
compaction inside a particularly challenging partially
thrombosed large wide-neck aneurysm; there was
continued residual filling on his subsequent follow-up.
A third procedure involving non-Neuroform stent was
performed on this patient which was complicated by a
late intracerebral hemorrhage despite Raymond class 1
occlusion on post-intracranial hemorrhage angiogra-
phy. There was no significant stenosis within the stent
constructs of the eighteen aneurysms with follow-up.
We continue to follow all patients in this series, and to
our knowledge, no others have had aneurysm-related
clinical problems.
DISCUSSION
The development of self-expanding intracranial stents
has increased the options for treatment of wide-necked
aneurysms. The original Neuroform device was
introduced as the first flexible stent made of a nickel-
titanium alloy (nitinol) designed for treatment of
intracranial wide-necked and fusiform aneurysms. This
device has been evaluated in a number of preliminary
studies [3, 6, 10, 16-19], demonstrating its efficacy,
safety, and satisfactory immediate anatomical results.
The largest series of Neuroform stents in the treatment
of aneurysms was recently published with excellent
results [20], and our experience with over 300
Neuroform stents mirrors this success. The present
Neuroform EZ series attests to the ease of using the
Neuroform EZ stent system, as well as the good
anatomical and clinical outcomes associated with other
Neuroform stents. 
Compared to the Neuroform 3 delivery system,
which required en bloc advancement of catheter and
loaded stent, the Neuroform EZ allows the operator to
select their desired micro-catheter without stent
transfer. The operator may obtain access with their
choice of microwire and microcatheter and avoid the
difficulty of en bloc advancement through tortuous
anatomy. The bumpers allow the stent to be moved
backward and forward prior to unsheathing to achieve
optimal positioning and microcatheter stability prior to
deployment. The stent-deployment wire has a tip that
extends beyond the microcatheter, and while this non-
navigable tip could potentially cause difficulty in stent
advancement, it was not a problem in our experience
due to adequate distal microcatheter access. Placement
of overlapping stents requires fewer steps because the
microcatheter and wire are left in place for loading
subsequent stents, providing a key advantage over the
Neuroform 3 design.
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most intracranial aneurysms, especially those with tight
curves in the parent vessel or located at bifurcation.
Though rare, limitations of microcatheter access can
favor another stent. The Neuroform 3 design may have
an advantage when insufficient distal microcatheter
access is obtained. The old design does not have a
leading wire on the stent deployment wire, so it can be
pushed out of the microcatheter with less distal access.
We sometimes use other stents like the Enterprise when
only smaller microcatheters can access the aneurysm.
The duration of anti-platelet therapy is not standard-
ized, but our strategy maintains dual anti-platelet
therapy for three months when a single stent is placed.
Complete endothelialization over a Neuroform stent
has been demonstrated in a similar time frame [2].
When using overlapping stents, we suspect that the
thromboembolic risk and time to endothelialization are
both increased; therefore, a six-month or longer dual
antiplatelet strategy is utilized. This may also be related
to the type of aneurysm being treated. Arteries with
segmental wall defects usually will require aneurysms
to be treated with overlapping stents to reconstruct
anatomy and avoid coil prolapse. It is unclear to date if
these stents will become completely “endothelialized”.
Aneurysms resulted from focal arterial wall weakness
usually require one stent reconstruction and are more
likely to become fully “endothelialized”. Antiplatelet
therapy in acute subarachnoid hemorrhage complicates
management. Unless absolutely necessary, we avoid or
delay placing stents when the patient is likely to have
other  procedures  including  ventriculostomy.
Antiplatelet strategy for stenting in the setting of acute
hemorrhage have been previously reported [21].
Clinical and angiographic follow-up revealed
excellent results in this preliminary study. We were
fortunate to have no significant complications from
Neuroform EZ procedures to this point. Furthermore,
the aneurysm population showed a trend toward
progressive thrombosis after treatment. While three
large aneurysms required retreatment for coil
compaction, we were satisfied with angiographic
results overall. A larger series and longer follow-up are
needed to elucidate the long-term efficacy and progno-
sis for aneurysms treated with the Neuroform EZ stent
delivery system, but the initial results are promising.
Stent deployment was easier using the newer system,
and we anticipate clinical outcomes to at least match
those of prior Neuroform generations. We validate with
this report the safety of the transfer technique for
intracranial stenting. 
In conclusion, the Neuroform EZ stent delivery
system is feasible, safe, and effective in treating wide-
necked intracranial aneurysms. In comparison to
previous generations, the Neuroform EZ stent system
offers improved stability and support in stent delivery
to the aneurysm site, which is especially useful for
overlapping multiple stents. The one recurrent techni-
cal problem of coil prolapse was managed with deploy-
ment of another stent when necessary. Though limited
in scale, this study is encouraging because it
demonstrates that devices like the Neuroform EZ stent
delivery system may continue to improve our ability to
treat wide-necked aneurysms with lower morbidity,
mortality, and re-treatment rates.
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